{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:16:41Z","timestamp":1790705801812,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiac sympathetic nerve system (SNS) might play an important role in arrhythmogenesis of arrhythmogenic cardiomyopathy (ACM). This study aims to assess the activity of cardiac SNS in ACM patients by heart rate variability (HRV), and to investigate its predictive value for sustained ventricular tachycardia (sVT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 88 ACM patients and 65 sex- and age- matched healthy participants were enrolled. The time domain measures were used to evaluate the activity of cardiac SNS. An independent cohort with 48 ACM patients was as the validation cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>ACM patients had lower levels of standard deviation of all NN intervals (SDNN) [118.0 (90.3, 136.8) vs. 152.0 (132.5, 174.5) ms,<jats:italic>p<\/jats:italic>&amp;lt; 0.001] compared with healthy participants. Further analysis showed ACM patients with sVT had lower levels of SDNN than those without sVT (105.0 \u00b1 28.1 vs. 131.8 \u00b1 33.1 ms,<jats:italic>p<\/jats:italic>&amp;lt; 0.001). Multivariate logistic regression analysis showed SDNN was independently associated with sVT in ACM patients [odds ratio (OR) 0.59, 95% confidence interval (CI) (0.45\u20130.78),<jats:italic>p<\/jats:italic>&amp;lt; 0.001]. Receiver operating characteristics curve demonstrated SDNN had clinical values in predicting sVT in ACM patients [area under the curve (AUC) = 0.73, 95% CI (0.63\u20130.84),<jats:italic>p<\/jats:italic>&amp;lt; 0.001], which was verified in the validation cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The present study suggests that HRV is impaired in patients with ACM, and the SDNN level has a moderate value in risk stratification for sVT in ACM patients. In addition, the finding might provide new target for the further management of ACM with integrated traditional Chinese and western medicine.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.1044797","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T04:40:18Z","timestamp":1667191218000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Impaired heart rate variability in patients with arrhythmogenic cardiomyopathy: A multicenter retrospective study in China"],"prefix":"10.3389","volume":"9","author":[{"given":"Baowei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuecheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aibin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41569-019-0200-7","article-title":"Molecular mechanisms of arrhythmogenic cardiomyopathy. Nature reviews.","volume":"16","author":"Austin","year":"2019","journal-title":"Cardiology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy.","volume":"376","author":"Corrado","year":"2017","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/eurheartj\/ehac180","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.","volume":"43","author":"Cadrin-Tourigny","year":"2022","journal-title":"Eur Heart J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.hrthm.2019.02.004","article-title":"The sympathetic nervous system and arrhythmogenic right ventricular cardiomyopathy: further evidence of a strong tie.","volume":"16","author":"Dusi","year":"2019","journal-title":"Heart Rhythm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jacc.2018.12.064","article-title":"Autonomic nervous system dysfunction: JACC focus seminar.","volume":"73","author":"Goldberger","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1161\/CIRCEP.113.001224","article-title":"Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy.","volume":"7","author":"Denis","year":"2014","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"f30","DOI":"10.1093\/europace\/euy007","article-title":"Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients.","volume":"20","author":"Denis","year":"2018","journal-title":"Europace."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm."},{"key":"B9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1161\/01.cir.89.2.667","article-title":"Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy.","volume":"89","author":"Wichter","year":"1994","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2967\/jnumed.111.088997","article-title":"Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias.","volume":"52","author":"Paul","year":"2011","journal-title":"J Nucl Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1093\/eurheartj\/ehz260","article-title":"Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.","volume":"40","author":"Gatzoulis","year":"2019","journal-title":"Eur Heart J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/hrt.71.3.215","article-title":"Diagnosis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Task force of the working group myocardial and pericardial disease of the European Society of Cardiology and of the scientific council on cardiomyopathies of the international society and federation of cardiology.","volume":"71","author":"McKenna","year":"1994","journal-title":"Br Heart J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria.","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.hlc.2019.11.009","article-title":"Night-time premature ventricular complex positively correlates with cardiac sympathetic activity in patients undergoing radiofrequency catheter ablation.","volume":"29","author":"Yu","year":"2020","journal-title":"Heart Lung Circ."},{"key":"B15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","article-title":"Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European Society of Cardiology and the North American society of pacing and electrophysiology.","volume":"93","author":"Malik","year":"1996","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.302549","article-title":"Role of the autonomic nervous system in modulating cardiac arrhythmias.","volume":"114","author":"Shen","year":"2014","journal-title":"Circ Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/CIRCRESAHA.116.304679","article-title":"Cardiac innervation and sudden cardiac death.","volume":"116","author":"Fukuda","year":"2015","journal-title":"Circ Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1161\/01.cir.101.13.1552","article-title":"Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography.","volume":"101","author":"Wichter","year":"2000","journal-title":"Circulation."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/eurheartj\/ehab772","article-title":"Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.","volume":"43","author":"Cerrone","year":"2022","journal-title":"Eur Heart J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1161\/circulationaha.119.039710","article-title":"Disruption of Ca(2+)i homeostasis and connexin 43 hemichannel function in the right ventricle precedes overt arrhythmogenic cardiomyopathy in plakophilin-2-deficient mice.","volume":"140","author":"Kim","year":"2019","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1161\/CIRCULATIONAHA.121.057757","article-title":"Exercise causes arrhythmogenic remodeling of intracellular calcium dynamics in plakophilin-2-deficient hearts.","volume":"145","author":"van Opbergen","year":"2022","journal-title":"Circulation."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1093\/eurheartj\/ehy600","article-title":"Treatments targeting inotropy.","volume":"40","author":"Maack","year":"2019","journal-title":"Eur Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10741-008-9132-8","article-title":"Beta-adrenergic stimulation and myocardial function in the failing heart.","volume":"14","author":"El-Armouche","year":"2009","journal-title":"Heart Fail Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/cvr\/cvu206","article-title":"Desmoglein-2 interaction is crucial for cardiomyocyte cohesion and function.","volume":"104","author":"Schlipp","year":"2014","journal-title":"Cardiovasc Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/CIRCRESAHA.116.309631","article-title":"Adrenergic signaling strengthens cardiac myocyte cohesion.","volume":"120","author":"Schinner","year":"2017","journal-title":"Circ Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41569-019-0221-2","article-title":"The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies.","volume":"16","author":"Herring","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/heartjnl-2021-319113","article-title":"Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.","volume":"108","author":"Bosman","year":"2022","journal-title":"Heart."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1093\/eurheartj\/ehac289","article-title":"Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.","volume":"43","author":"Jorda","year":"2022","journal-title":"Eur Heart J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/eurheartj\/ehac235","article-title":"Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.","volume":"43","author":"Protonotarios","year":"2022","journal-title":"Eur Heart J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.hrthm.2019.01.019","article-title":"Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.","volume":"16","author":"Assis","year":"2019","journal-title":"Heart Rhythm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jacc.2013.05.035","article-title":"A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.","volume":"62","author":"Li","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3760\/cma.j.issn.0366-6999.2011.1.015","article-title":"Evaluation of the traditional Chinese medicine shensongyangxin capsule on treating premature ventricular contractions: a randomized, double-blind, controlled multicenter trial.","volume":"124","author":"Zou","year":"2011","journal-title":"Chin Med J (Engl)."},{"key":"B33","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.3760\/cma.j.issn.0366-6999.20130135","article-title":"Effects of shensongyangxin capsule on heart rate turbulence and heart rate variability in chronic heart failure.","volume":"126","author":"Yang","year":"2013","journal-title":"Chin Med J (Engl)."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3480276","article-title":"Identification of target genes of antiarrhythmic traditional chinese medicine wenxin keli.","volume":"2020","author":"Yao","year":"2020","journal-title":"Cardiovasc Ther."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1044797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T22:07:25Z","timestamp":1728252445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1044797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":34,"alternative-id":["10.3389\/fcvm.2022.1044797"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1044797","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"article-number":"1044797"}}